The guidance encourages the use of Bayesian statistics in drug trials. Instead of starting from scratch and only adding new information from the trial, the framework allows researchers to incorporate ...
Ideally, specific treatment for a cancer patient is decided by a multidisciplinary tumor board, integrating prior clinical experience, published data, and patient-specific factors to develop a ...
The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...
WASHINGTON, Jan. 20, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in clinical trials, formally recognizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results